[PDF] from goodsamhosp.orgJ Hsia, JG MacFadyen, J Monyak… - Journal of the American …, 2011 - Elsevier During a median follow-up of 2 years (range up to 5 years), rates of the primary trial endpoint were 1.18, 0.86, and 0.44 per 100 person-years in the placebo group (n = 8,150) and rosuvastatin groups without LDL-C <50 mg/dl (n = 4,000) or with LDL-C <50 mg/dl (n = 4,154), ... Cited by 2 - Related articles - All 6 versions
D Rodriguez-Luna, M Rubiera, M Ribo… - Stroke, 2011 - Am Heart Assoc Results—Although LDL-C levels were not correlated with ICH volume (r=−0.18; P=0.078) or National Institutes of Health Stroke Scale score (r=−0.17; P=0.091) at baseline, lower LDL-C levels were associated with HG (98.1±33.7 mg/dL versus 117.3±25.8 mg/dL; P=0.003), ...
J Claude Tardif, M McGowan… - Journal of the …, 2011 - Am Coll Cardio Found ... Pharmacology/Hormones/Lipids—Clinical Presentation Number: 920-3 ... PATIENTS WITH SEVERE HETEROZYGOUS ADDED TO MAXIMALLY TOLERATED LIPID-LOWERING REDUCES LOW-DENSITYLIPOPROTEINCHOLESTEROL WHEN APOLIPOPROTEIN ... All 2 versions
JD Otvos, S Mora, I Shalaurova, P Greenland… - Journal of Clinical …, 2011 - Elsevier LDL-P measured by nuclear magnetic resonance spectroscopy, calculated LDL-C, and carotid intima-media thickness (IMT) were assessed at baseline in the Multi-Ethnic Study of Atherosclerosis, a community-based cohort of 6814 persons free of clinical ... Cited by 3 - Related articles - All 4 versions
AD Sniderman, K Williams, JH Contois… - … Quality and Outcomes, 2011 - Am Heart Assoc From the Mike Rosenbloom Laboratory for Cardiovascular Research, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada (ADS); KenAnCo Biostatistics and University of Texas Health Science Center at San Antonio, San Antonio, TX (KW); ... Cited by 1 - Related articles - All 3 versions